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ABSTRACT
Post-traumatic Stress Disorder (PTSD) is a debilitating psychiatric disease that
often follows acute or chronic exposure to extreme stress. Hallmarks of this disorder
include stressors, intrusion symptoms, avoidance, negative alterations in cognition and
mood, and alterations in arousal and reactivity (Bovin, 2015). Since it was first defined in
the Diagnostic and Statistical Manual of Mental Disorders-III (DSM-III), the diagnostic
criteria for PTSD have evolved to encompass stressors as they may occur repeatedly
across the lifespan (Bovin, 2015). Physiological and behavioral consequences of this
extreme stress manifest themselves as systemic alterations in form and function. As is
true of many diagnosable conditions, PTSD is most prevalent in African Americans and
an estimated one in 11 people will be diagnosed in their lifetime (Torres, 2020). More
recent studies have elucidated that race-based traumatic stress elicits a chronic stress
response that mimics that of PTSD (Carter, 2020). While this disorder causes primary
changes to the brain, further downstream effects cause global corporal alterations and
lead to maladaptive responses to future stressors.
Previous studies have demonstrated that the hippocampus, amygdala, and medial
prefrontal cortex play important roles in PTSD. Studies have expanded on these findings
and traced their effects downstream in other body systems including the immune system,
central nervous system, digestive system, and endocrine system (Stam, 2007). Though
there is a significant understanding of the psychological and physiological manifestations
of PTSD, the interactions of the distal branching effects of this disorder on the body are
less substantiated as they relate to racial trauma. Only more recently have researchers
begun to examine their findings through an interdisciplinary lens as they apply to race.
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This capstone project is a literature review of the chronic stress response, secondary and
downstream effects of stress on the numerous body systems, and their integrated
implications on health as they relate to race-based stress. The research collected explores
the physiological and neurobehavioral alterations which take place secondary to general
trauma exposure, the long-term consequences of chronic stress, and the role of race as a
social determinant of health. Various medical and academic interventions will be
discussed, as well as the secondary effects of racial trauma on people of color.
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INTRODUCTION
Allostasis and the Individual Stress Response
Stress has many working definitions but is concisely defined as an emotional or
physical stimulus that disrupts homeostasis and may result in pathology (Stam, 2007).
This response is non-specific as it does not affect one particular system, but many parts of
the global system due to their inherent connections. Levine and Ursin (2013) defined
stress as a condition caused by a lack of information leading to uncertainty or
unpredictability about obtaining positive outcomes or avoiding negative outcomes. Such
stress may follow a potential threat to the vital interests of the organism in which
physiological and behavioral mechanisms are activated to eliminate the source of the
stress and restore homeostasis (Levine and Ursin, 2013). Stress is a normal and essential
physiological response, but when these responses become unregulated or occur in excess,
problems arise.
Systemic changes occur following exposure to stressors. Much like the immune
system, the body as a whole changes following exposure to specific and controllable
stressors. These stressors prime the system for more refined and efficient responses
during a second encounter. The subsequent changes are less adaptive when the source of
stress is not immediately controllable (Stam, 2007). As stated by Stam (2007), when the
source of stress is not acutely constrained, the stress response triggers a reorganization of
neuronal circuitry in the brain and an acquisition of novel strategies to address the threat.
If the stress response is repeated or sustained for an extended period without removal of
the stressor, or if the stressful experience is so overwhelming that it over-taxes the
homeostatic mechanisms, this “allostatic overload” may precipitate disease (Stam, 2007).
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Allostasis is defined as achieving stability through change, or the process by
which the organism maintains homeostasis in the face of new challenges (Faber, 2020).
Allostatic systems enable an organism to maintain its essential functions in balance
(McEwen, 2017). To maintain an allostatic state, the brain overrides the local effects of
homeostasis in individual organs to allow for optimal global functioning. Allostasis is
ultimately beneficial in that it allows for adaptation over time. This adaptation is achieved
via ongoing evaluation of internal and external demands which permit physiological
adjustments in advance of stress via anticipatory arousal (Ganzel, 2010).
Per McEwen (2017), the body initiates an allostatic response under normal
circumstances to cope with a stressor for the duration of its presence. Once the challenge
has passed, the body turns this response off. Two primary mediators of this ever-adapting
system are the sympathetic nervous system and the Hypothalamic-Pituitary-Adrenal
(HPA) axis. The activation of these systems leads to the release of catecholamines and
other accompanying hormones, such as cortisol, while the deactivation results in a
regression to baseline hormonal concentrations. When the allostatic response is limited to
the period of challenge, adaptive protection outweighs adverse consequences. However,
with persistent stress over weeks, months, or even years, the body is exposed to elevated
levels of stress hormones and allostatic overload, resulting in pathophysiological damage
(McEwen, 2017). McEwen went on to define allostatic load as the physiological cost
associated with long-term, global changes across the body systems to match internal
functioning to external demand. With persistent stress, the body’s delicate and
overlapping regulatory systems are overtaxed. This wear and tear can create runaway
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dysregulation and leave these regulatory mechanisms catastrophically out of alignment
(McEwen, 2017).
Under normal physiological conditions, the system’s response to stress is highly
individualized but ultimately occurs within stable and predictable limits defined by
homeostasis. The individuality of the stress response depends on an individual’s appraisal
process, coping style, and social milieu. Individuals will experience a variable stress
response based upon their experience of uncertainty and their subsequent appraisal of
their ability to restore homeostasis. The appraisal process may be influenced by a
person’s social environment, race, ethnicity, biological sex, gender identity,
socioeconomic status, and various other intersecting social determinants of health. In an
example offered by Stam (2007), PTSD is more prevalent in biological females not
necessarily due to increased exposure to traumatic events, but likely due to differences in
coping styles, socio-economic resources, and levels of autonomic and hormonal arousal.
Stam (2007) went on to explain that the psychological factors involved in gender-based
differences in PTSD occurrence also play a role in gender-independent differences in
PTSD vulnerability (Stam, 2007).
Part of this stress response process depends on a person’s locus of control. In a
study conducted by Karstoft (2015), locus of control and coping style were found to be
highly predictive of PTSD outcomes. Specifically, an internal locus of control was
correlated with a decreased risk of PTSD symptoms, as was the employment of problemfocused coping strategies as opposed to emotion-focused coping (Karstoft, 2015).
Inability to cope with stress may result in clinically significant consequences in
functioning, such as post-traumatic stress. Per the Diagnostic and Statistical Manual of
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Mental Disorders-5 (DSM-5), higher rates of PTSD have been reported among U.S.
Latinx, African Americans, and American Indians compared to other ethnic
demographics (Trauma- and stressor-related disorders, 2013).
The stress response is made increasingly discrete and unpredictable by the
involvement of epigenetic factors, particularly those involved in the pathogenesis of
PTSD. Dr. Madhulika Gupta, M.D. (2013) stated environmental factors such as early life
stress can modify gene expression via DNA methylation and histone modification. DNA
methylation has been found to reduce gene expression while early life stressors have been
implicated in the increased methylation of glucocorticoid receptor expression. The
glucocorticoid receptor plays a critical role in the negative feedback regulation of the
HPA axis. On a systemic level, these epigenetic mechanisms have been associated with
the mechanisms of fear learning and memory consolidation which play a central role in
PTSD (Gupta, 2013).

7

BACKGROUND
Post-traumatic stress disorder (PTSD)
The American Psychiatric Association revised the diagnostic criteria of posttraumatic stress disorder (PTSD) in its fifth edition of the Diagnostic and Statistical
Manual of Mental Disorders (DSM-5). Per this most recent definition, PTSD is defined
as “the development of characteristic symptoms following exposure to one or more
traumatic events.” These characteristic symptoms include intrusion symptoms,
avoidance, negative alterations in cognition and mood, and alterations in arousal and
reactivity. Intrusion symptoms include involuntary memories, recurrent and distressing
dreams, and realistic flashbacks about the traumatic event. These intrusion symptoms are
accompanied by avoidance of internal and external stimuli associated with the event.
PTSD is distinguished from other trauma- and stressor-related disorders based on both
timing and symptom profile (Trauma- and stressor-related disorders, 2013).

Table 1. Symptoms required for diagnosis of PTSD. Adapted from Bisson, 2015.
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Per the DSM-5, an appropriate PTSD diagnosis may specify whether the
individual’s symptoms include intrusion symptoms such as depersonalization or
derealization, or if these symptoms occurred with delayed expression. The functional
consequences of this disorder include impaired functioning across social, interpersonal,
developmental, educational, physical health, and occupational domains (Trauma- and
stressor-related disorders, 2013). The manifestations of this disorder exist on a spectrum,
but nearly ubiquitously affect diagnosed individuals daily.

The Chronic Stress Response
The hallmark psychological symptoms of PTSD are associated with various
somatic symptoms and medical conditions affecting multiple body systems. Further,
these primary physical effects of PTSD are accompanied by secondary alterations in
experience and quality of life. With the experience of chronic stress and allostatic
overload, an individual’s health is markedly affected. As hormones such as cortisol
circulate in the body, fat is mobilized as sugar for use in the fight-or-flight response.
Unused sugar is re-stored as fat in the midsection, potentially damaging the vital organs
located in the region. The elevation of blood pressure and heart rate which accompany
this sympathetic response can, in excess, lead to hypertension or cardiomegaly
(Greenberg, 2020). Beyond the diagnosable symptoms of PTSD, chronic stress causes
significant alterations across multiple mechanisms and profoundly exaggerates systemic
damage.
Following exposure to a traumatic event, individuals diagnosed with PTSD
experience notable changes in neuroanatomy, as well as the CNS. Structural and
functional changes in the brain have been linked with the chronic experience of stress and
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the exacerbation of PTSD symptoms such as hypervigilance. Holmes (2018) identified
structural and functional alterations in the prefrontal cortex (PFC), hippocampus,
amygdala, and cerebellum. Structurally, individuals with PTSD presented with smaller
cerebellar, hippocampal, and PFC volume. Functionally, connectivity in the cerebellum
and PFC were negatively correlated with PTSD severity, while the amygdala
demonstrated increased activity. Analyses in this study revealed weakened connectivity
within nodes of the central executive network of the PFC, as well as between nodes of the
default mode network in the PFC and cerebellum. These deficits in cerebellar
connectivity manifested as symptoms such as intrusive thoughts and avoidance. These
findings were consistent with well-established knowledge on PTSD pathophysiology and
the growing support of the involvement of the cerebellum (Holmes, 2018).
As has been established, patients diagnosed with PTSD develop neuroanatomic
changes in the hippocampus, amygdala, and cortex. Reduced volume and activity in the
amygdala alter stress responses and the extinction of memories. Increased activity in the
amygdala promotes hypervigilance and impairs discrimination of threats. Reduced
prefrontal cortical volume dysregulates executive function, reduced anterior cingulate
volume impairs the extinction of fear responses, and decreased medial prefrontal
activation leads to uncertain effects. These modifications cause neural circuitry to
reorganize in a form of non-associative learning to strengthen defensive reflexes to
previously neutral stimuli (Sherin, 2011).
Per Bremner (2006), persons with PTSD show increased cortisol and
norepinephrine responses to stress, consistent with the traumatic stress response. In the
long-term, these neurochemical systems become dysregulated in an attempt to cope with
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fear. As is summarized in the image below, corticotropin-releasing hormone (CRH), part
of the HPA axis, is released from the hypothalamus in response to stress. This stimulates
the release of adrenocorticotropic hormone (ACTH) from the pituitary and the
subsequent release of cortisol from the adrenal gland. This eventually results in negative
feedback on the HPA axis. While cortisol facilitates survival in instances of acute danger,
it is accompanied by CRH which centrally mediates fear behaviors and triggers
downstream neurochemical responses to stress. One of these downstream responses
involves the noradrenergic system located in the locus coeruleus of the brain stem. This
system is associated with increased alertness and hypervigilance. As this neural circuitry
becomes reorganized over time, the brain’s defensive reflexes against previously neutral
stimuli are maladaptively strengthened. This learned hyperresponsivity has lasting effects
on the rest of the body (Bremner, 2006).

Figure 1. Lasting effects of trauma on the brain. Adapted from Bremner, 2006.
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Neurobiological features of PTSD occur with abnormalities and further functional
implications. The proinflammatory cytokines and stress hormones of the HPA axis do not
exist in a vacuum, but are systemically impactful. Neuroendocrine shifts such as
hypocortisolism and increased CRH drive abnormal stress processing and promote
hippocampal atrophy, respectively. Parallel imbalances in the T3:T4 thyroid hormone
ratio increase subjective anxiety (Sherin, 2011).
Variations in neurochemicals including catecholamines, serotonin, amino acids,
and peptides each contribute to marked PTSD symptomatology. Increases in
catecholamines such as dopamine and norepinephrine (NE) interfere with fear
conditioning and increase arousal in the startle response. NE specifically increases pulse,
blood pressure, and response to memories in individuals diagnosed with PTSD.
Decreased serotonin levels in the many parts of the raphe nucleus disturb the dynamics
between the amygdala and hippocampus, compromise anxiolytic effects, and increase
vigilance. Decreases in amino acids such as GABA similarly increase anxiolytic effects,
while increases in glutamate foster derealization and dissociation. Decreased plasma
neuropeptide Y (NPY) leaves CRH and NE unopposed and upregulates the stress
response. Increases in CSF β-endorphin levels foster numbing, stress-induced analgesia,
and dissociation. These many changes stimulate the sympathetic nervous system (SNS)
and trigger a potentially untimely fight-or-flight response. This hyperresponsivity of the
CNS leads to altered processing of visceral and sensory stimuli (Sherin, 2011).
On a broader scale, traumatic stress in PTSD often co-occurs with global changes
in immune function. These systemic changes include altered glucocorticoid sensitivity in
immune cells, elevated proinflammatory cytokines, and shifts in immune cell distribution
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(Neigh, 2016). Neigh (2016) described multiple candidate mechanisms of immune
dysfunction in PTSD. While the dogmatic understanding of PTSD associates the disorder
with elevated cortisol and catecholamine concentrations in response to stress, excessive
activation of the HPA axis in this pathophysiology results in reduced circulating cortisol
levels. In response to a sustained increase in CRH and this excess activation, CRH
receptors are downregulated. This results in a reduction of downstream cortisol secretion
and increased glucocorticoid sensitivity. These changes are linked to increased cytokine
production and the hyper-inflammatory state comorbid with PTSD (Neigh, 2016).
The chronic low-grade inflammation consistent with PTSD is linked to numerous
inflammatory biomarkers. The proinflammatory cytokines tumor necrosis factor α (TNFα), interleukin-1β (IL-1β), and interleukin-6 (IL-6) have been implicated in the
augmentation of PTSD symptoms in response to subsequent stressors. Cytokines
additionally influence the HPA axis’ signaling capabilities and impair cellular processes
by stimulating oxidative stress. Studies have associated reactive oxygen species and
proinflammatory cytokines with multiple sequelae of PTSD (Neigh, 2016).
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Figure 2. A psychoneuroimmunological model of PTSD. Adapted from Neigh, 2016.
While PTSD has been heavily correlated with several physical ailments,
associations of this disorder with cardiovascular disease (CVD) are of particular concern.
The cardiovascular consequences of psychological trauma were described by Arenson
(2017) as occurring in both immediate and delayed fashions. Of note, individuals with
PTSD are twice as likely to die from CVD compared to control groups. In the described
participant group, each incremental increase in PTSD symptoms corresponded to a 20%
increase in the risk of heart disease mortality (Arenson, 2017). Buckley (2001) observed
that compared to non-trauma-exposed individuals, individuals carrying a PTSD diagnosis
have higher resting heart rates and elevated blood pressures. These positive associations
between PTSD and basal cardiovascular activity were consistent with established
findings in this field of research (Buckley, 2001). Chronic cardiovascular
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hyperresponsivity, and the catecholamine dysregulation discussed previously, could put
individuals with PTSD at risk for further pathological changes.
In addition to CVD, PTSD has been established as a risk factor for both
myocardial infarction (MI) and stroke (Remch, 2018). Remch (2008) went on to describe
the negative role PTSD played in the individual healths of the study’s participant pool.
Weight gain, tobacco and alcohol use, hypertension, and hyperlipidemia are all
comorbidities of PTSD. Therefore, the negative effects of these afflictions are inseparable
from a patients' general condition and, in particular, their increased risk of cardiac
incident (Remch, 2008).
At the intersection of the physical and emotional responses to stress is the gut. A
system of bidirectional communication exists between the CNS and the digestive system
called the gut-brain axis (GBA). Clapp (2017) expanded upon a growing field of research
supporting the association of stress with gastrointestinal and extragastrointestinal
diseases. Inversely, recent studies have also related dysbiosis and inflammation of the gut
with mental illnesses such as anxiety and depression, which share prevalent
symptomatology with PTSD. The resulting pathophysiology relating to this GBA
dysfunction includes stress-induced mucosal immune alterations in intestinal
permeability and impaired CNS ability to downregulate incoming visceral or somatic
signals (Clapp, 2017).
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Figure 3. Gut-brain axis pathway diagram. Adapted from Clapp, 2017.

In a study conducted by Gradus (2017), PTSD was associated with diagnosed
upper and lower GI disorders, as well as irritable bowel syndrome (IBS),
gastroesophageal reflux disorder, and dyspepsia. The risk of GI disorder among PTSD
patients was observed at 25% with an overall incidence rate 1.8 times higher than that of
the general population. While the observed risk of malignancy varied with each specific
disorder, compelling evidence was found associating PTSD with peptic ulcers,
esophagitis, cholelithiasis, gastritis, and duodenitis. Additionally, these authors found
evidence of effect modification by psychiatric PTSD comorbidities including depression
and substance abuse (Gradus, 2017).
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Unlike psychological comorbidities of trauma, which can develop in sequence or
without a discernable pattern, physical post-traumatic symptomatology typically develops
in parallel with the traumatic incident. Considerable physiological factors are common to
both PTSD and chronic pain and are likely mutually reinforcing on a systemic level. The
prevalence of PTSD is substantial in patients with chronic pain. Per Dr. Lorie
DeCarvalho, Ph.D. (2019) of the U.S. Department of Veteran Affairs, 35% of current
chronic pain patients also carry a diagnosis of PTSD compared to 3.5% of the general
population. Inversely, the prevalence of chronic pain in individuals with PTSD is greater
than in controls. Not only do individuals with PTSD experience higher rates of chronic
pain, but this pain is quantified as increasingly intense when compared to control groups
(DeCarvalho, 2019).
In addition to the increased incidence of chronic pain in individuals with PTSD,
this affected population experiences various alterations in pain perception. Compared to
control groups, individuals with PTSD displayed hyposensitivity to pain accompanied by
hyper-reactivity to suprathreshold noxious stimuli. These features are likely attributable
to alterations in emotional interpretation and sensory processing of painful stimuli
(Defrin, 2008).
The inter-systemic effects of PTSD compound on one another and cause damage
to the body over time. The compounding effects of these multiple pathologies accelerate
the already grueling disease process of PTSD. These effects of chronic stress have
secondary effects which place individuals at higher risk for comorbidities, alter their
abilities to develop innate and adaptive immunity, shorten their telomeres, and place them
at risk for serious illness, such as diabetes, heart disease, and COVID-19.
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Racism at the Cellular Level
As stated by Kirkinis (2018), race as a social construct is well-established in the
United States and has been used to categorize people into groups for centuries. This
practice of grouping humans based on their eye shape, nose shape, hair texture, skin tone,
etc. has resulted in racial groupings. These racial groupings exist in a social hierarchy
that places Whites at the top and all people of color beneath that dominant group. As a
result of this hierarchy, African Americans, Asians, Latinx, and Native Americans have
and continue to endure systems of oppression as targets of variable forms of racism.
Racism manifests as racial discrimination or the combination of ideological racial
superiority with social structures associated with dominance and oppression. The
subsequent normalization of these widespread inequities is called structural racism
(Kirkinis, 2018).
Increasing evidence exists demonstrating the connection between racial
discrimination and a variety of negative physical and mental health outcomes.
Continuous with the definition of stress as “the inability to meet the demands of a
situation,” consequences exist for the experiential stress of racism or racism-related
stress. When this race-based stress initiates a maladaptive psychological response, the
resulting wounds to the self closely align with those observed in PTSD (Kirkinis, 2018).
A growing body of research exists which explores the impact of racist and
discriminatory encounters on physical health. Empirical evidence supporting the validity
of these studies consistently mirrors that of studies conducted in the field of chronic
stress. Harrell et al. (2003) established that external stressors associated with acts of
racism changed physiological functioning in affected individuals, ultimately contributing
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to negative health outcomes. In this research, Harrell found that reactions to racism
including anxiety and worry prompted rehearsed defensive reactions and aggressive
responses as methods of coping and adaptation (Harrell, 2003). Examples of altered
biological function in response to the physiological stress response include preterm or
low birth weight deliveries, increased incidence of heart disease, and hypertension
(Carter, 2007).

RESEARCH STRATEGIES
To ensure a high-quality review of literature, a comprehensive search was
performed of peer-reviewed journals obtained from reputable databases. These databases
included Google Scholar, NCBI, and PubMed Central. Further resources were obtained
from the reference sections of each respective citation. All data and information
discussed in this review were obtained by reading and reviewing this literature. Searches
were refined based on article credibility and date of publishing.
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DISCUSSION
Racial Disparities in Medicine
Independent of race’s biological significance on an individual level, the societal
and social consequences of racism are substantial and indisputable. Due to the continued
dependence on race as a social stratifier in the United States, the resulting racial hierarchy
has contributed to marked inequalities in power, opportunity, resources, and social status
(Dominguez, 2008). These inequalities are experienced by individuals of affected
populations at a molecular level. The weathering effects of living in a race-conscious
society are greatest among people of color, especially African Americans (Geronimus,
2006). Research conducted in the realm of discrimination and racism suggests that the
effects experienced by targeted individuals are consistent with those described in
traumatic stress research (Carter, 2007). Pioneer to this field of study, Clark (1999) and
Slavin (1991) asserted the perception of racism and racial hostility initiates stress
reactions. The secondary and long-term effects of racial trauma manifest as systemic
dysfunctions such as IBS and coronary artery disease (CAD), deterioration of birth
outcomes, and emotional injury.
Studies cited by Carter (2007) suggest that acute exposure to racism is associated
with increased cardiovascular activation (CVR), while past exposure to racism impacts
current CVR in reaction to race-related stressors. This finding supports the increased
prevalence of self-reported stress and physiological response following repeated or
sequential racial encounters in people of color (Carter, 2007). In addition to this increased
incidence of CAD, race has been identified as a precipitating factor in the lifetime
occurrence of hypertension, myocardial infarction, and stroke. Hypertension is more
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prevalent in African Americans than any other racial group and is known to increase the
risk for CAD and stroke (American Heart Association, 2015). These cyclic comorbidities
mimic those associated with cardiac dysfunctions in PTSD pathology.
The association between IBS and PTSD has been previously established in nonminority populations. Iorio (2014) investigated the same association in African American
individuals, uncovering a significant relationship. This study produced results supporting
an association between IBS and PTSD in people of color. African American individuals
with IBS were twice as likely to suffer from PTSD, but this relationship is neither
directional nor causal. Iorio went on to state that while the participants of this study
carried histories of IBS before their subsequent PTSD diagnoses, it is impossible to
determine which dysfunction preceded the other. IBS symptoms in this study’s
participants were often accompanied by bodily pain, inhibition of social functioning, and
mental health deficits. Each of these additional symptoms negatively correlates to PTSD
severity (Iorio, 2014).
The preceding physiological responses to racism and discrimination are
moderated by variables of personality and cultural orientation (Harrell, 2003). Racism
harms both physical and mental health. This impact, however, is not reflected in the
theories of current psychological or psychiatric assessment models. Similar to the
variability of the individual stress response, which depends upon appraisal and coping,
researchers have asserted that stress outcomes relating to racial trauma vary based on
racial group identity, frequency of discrimination, and severity of the traumatic event(s).
The occurrence of such race-based incidents is positively associated with lower levels of
physical health and higher levels of psychological distress (Carter, 2007). With these
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observations in mind, emotional injury resulting from racial trauma should be assessed as
a psychological symptom of racism with equal diagnostic significance to physical and
mental health exam findings.
Race-based Medicine
Despite the failure of racially targeted drugs such as BiDil, a heart medication
marketed toward African Americans, no clear guidelines exist on the use of race in
medicine. Although sizable evidence exists disputing this notion, the belief that race is a
reliable proxy for genetic difference has become insidiously embedded in medicine
(Vyas, 2020). Subtle examples of this insidious insertion of race in medicine are observed
in diagnostic algorithms and practice guidelines that adjust their outputs based on a
patient’s racial or ethnic identification. These algorithms are employed to guide clinical
decision-making but, due to their consideration of race, actively perpetuate race-based
health inequities. A significant danger of these race-adjusted algorithms is the potential
swaying of clinical decision-making in favor of white patients (Vyas, 2020).
As stated by Vyas (2020), The American Heart Association’s Get with the
Guidelines - Heart Failure Risk Score predicts the risk of mortality in patients with acute
heart failure. This race-corrected stratification tool creates inequities by raising the
threshold for using clinical resources for black patients. By awarding three points to the
risk scores of non-black patients, black patients are thereby regarded as lower risk.
Similarly, equations used by cardiac surgeons to determine the risk of operative mortality
and major complications quantify black patients as having up to 20% greater risk than
white patients. When used preoperatively, this calculation may steer black patients away
from such procedures (Vyas, 2020).
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Similar race-considering algorithms and practices exist throughout medicine,
namely in Urology, Pulmonology, Endocrinology, Oncology, Nephrology, and
Obstetrics. In the case of obstetrics, the Vaginal Birth after Cesarean (VBAC) algorithm
is used to estimate the probability of successful vaginal birth following a prior cesarean
section and further counsel patients on their medical decisions. This algorithm accounts
for race by subtracting from the projected success rate in patients identifying as black or
Hispanic. The lower estimates of success produced from this algorithm may dissuade
clinicians from recommending vaginal deliveries to people of color and have concretely
resulted in higher rates of cesarean section in non-white women (Vyas, 2020). This
dynamic actively exacerbates preexisting racial disparities in obstetrics and gynecology,
including heightened maternal mortality and morbidity rates in black mothers (Vyas,
2019).
Further investigating the concept of obstetric racism, the Centers for Disease
Control and Prevention (CDC) conducts national pregnancy-related mortality and
morbidity surveillance to better understand the present differential reproductive outcomes
in the United States. The Pregnancy Mortality Surveillance System (PMSS) defines a
pregnancy-related death as one occurring while a woman is pregnant (or within 1 year of
pregnancy) which is aggravated or otherwise caused by the pregnancy. Since the
implementation of this surveillance, trends in pregnancy-related mortality ratios have
revealed considerable disparities based on race and ethnicity (Centers for Disease Control
and Prevention, 2020).
Per the CDC (2020), black mothers are three to four times more likely to die due
to pregnancy-related causes than white women. Additionally, black women are more than
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twice as likely to experience severe maternal morbidity. The causes of these pregnancyrelated deaths vary to some degree, but the contributions of chronic health conditions
such as hypertension, diabetes, and chronic heart disease have increased in recent years
(Centers for Disease Control and Prevention, 2020). It is not by coincidence that the
conditions which underlie a large number of pregnancy-related deaths are synonymous
with both the conditions disproportionately affecting black and other minority
populations, and those which co-occur with PTSD. This variable risk of complications
based on race and ethnicity is likely precipitated by several factors including access to
care, quality of care, prevalence of chronic disease, structural racism, and implicit biases
(Hall, 2015).

Figure 4. Graph of Infant Mortality Rates by Race and Ethnicity. Adapted from Centers
for Disease Control and Prevention, 2020.

Unlearning Racial Bias
The National Academy of Medicine (NAM) has reported that racial and ethnic
minorities receive lower-quality health care than their white counterparts, even when

24

income and education are taken into account. The NAM has additionally documented that
despite the poverty in which people of color disproportionately live, this fact alone cannot
account for their shortened lifespans when compared to white individuals. Perhaps even
more disturbing is that black patients are more likely to receive “less desirable
treatments.” Khiara Bridges (2017), a professor of law and anthropology, offered
examples such as higher rates of limb amputation and antipsychotic use, despite
mounting evidence against them, as examples in her discussion of this second-rate
treatment (Bridges, 2017).
With these facts in mind, scholars have begun to question the impact of racial
biases, whether conscious or unconscious, in healthcare. While physicians’ explicit racial
bias is plausibly not to blame for these disparities, it is also unlikely that these
inconsistencies in care have emerged as a result of physicians’ intention to cause their
patients harm. Physicians, despite their extensive medical educations, are not beyond
exposure to society’s negative racial discourse. Resulting unconscious negative attitudes
about “othered” racial groups are likely to blame for the inferior care provided to patients
of color. These individual biases, however, do not operate independently of the systems
which, too, contribute to the compromised care afforded to these marginalized groups
(Bridges, 2017).
Race, as a social construct, reflects the impact of polarized social experiences on
health outcomes. However, race is often misrepresented in preclinical curricula as a
biological category based on innate genetic differences. In this way, medical schools may
potentially play a role in propagating physician bias. Fortunately, the use of race in
medical education is an opportune area for improvement. Correction of this content
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through the use of standardized language, appropriate contextualization, and evidencebased teachings will allow student physicians to unlearn race-based fallacies instilled by
society (Amutah, 2021).
A step toward improving the uses of race and ethnicity in medicine includes
careful interpretation of disease outcomes without assumption of race- or ethnicityspecific cause. Abandoning the use of race and ethnicity in medicine entirely is by no
means a solution to this problem. Doing so would enable inequitable care systems to
persist via a diversity-blind approach. Instead, the substitution of better disease predictors
— such as genotypes, genetic ancestry, and biomarkers — could be used to address and
eliminate inequities in research and medicine (Borrell, 2021).
Ultimately, the lived experience of racial trauma evokes pathophysiology in the
body congruent to that of PTSD. The inclusion of racism in the trauma-focused care
vernacular is imperative to standardize healthcare for people of all races and ethnicities.
Intervention to mitigate the aforementioned inequities is both an urgent and necessary
responsibility of all current and aspiring healthcare professionals. To this end, the
maintenance of such racist tools and practices must be scrutinized and their improvement
made a priority across all realms of medicine. Advocacy on behalf of the most
marginalized individuals in our society will effect change to the benefit of those
considered more centralized in this movement.
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RECOMMENDATIONS FOR FUTURE STUDIES
Downstream disordered functioning following trauma exposure is wellestablished and verbosely supported, but discounts the ramifications of racism. A gap
exists in the literature regarding the long-term effects of PTSD in non-white individuals,
particularly concerning the role of racism as part of the disease process. Where research
has been minimally and insufficiently conducted, it has focused primarily on the effects
of racism in medicine and differential outcomes as they relate to African American
patients. Because of these research gaps, it is impossible to assert a causal relationship
exists between acts of race-based discrimination and observable physical and emotional
symptoms consistent with the racial trauma response. This begs the question, how do
these same effects impact other minority groups such as Hispanic/Latinx, Asian
American Pacific Islander, and Native American individuals? Can the concept of
traumatic discrimination rooted in racial trauma be applied to the discriminatory practices
impacting individuals who identify as part of the LGBTQIAP+ community? Longitudinal
studies focused on these minority groups could begin to fill this gap. Particular areas of
interest include hypervigilance concerning the current political climate, PTSD across the
lifespan in response to racial trauma, and the chronic stress sequelae related to COVID19.
Progress in this field of study demands that the next edition of the DSM include
racism as a potential stressor in PTSD. The current definition and criteria required for
appropriate PTSD diagnosis neglect stressful events associated with the experience of
racism and racial discrimination. Expansion of the conceptualization of trauma must
account for non-life-threatening events which present a psychological threat and result in
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emotional pain (Kirkinis, 2018). Without these evolved diagnostic criteria, affected
populations will remain excluded from proper care and without appropriate therapeutic
interventions.
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